Although AhR agonism is typically thought of with respect to enzyme induction, there is some evidence to suggest AhR agonism decreases Cyp3a and Cyp2c11 expression, which may be a mechanism for the effects we observed in our rat model of CKD (Shaban et al, 2005). This evidence concerns the gene AHR and chronic kidney disease.